Coding Bio

Coding Bio is a biotechnology company using machine learning and high-throughput screening to design chimeric antigen receptor and bispecific T cell engager therapies.

The company's platform screens millions of modular protein candidates in living cells to identify designs that best induce immune responses, generating proprietary data that feeds iterative ML models.

Coding Bio focuses on improving the clinical efficacy of cell therapies beyond binding affinity alone, applying learnings across disease states to accelerate candidate selection.